Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury.
about
Protease regulation: the Yin and Yang of neural development and diseaseEarly Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature MouseADAM8 is selectively up-regulated in endothelial cells and is associated with angiogenesis after spinal cord injury in adult miceMatrix metalloproteinase-3 accelerates wound healing following dental pulp injuryTwo faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activationOvercoming macrophage-mediated axonal dieback following CNS injuryVariants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke.Gait analysis in normal and spinal contused mice using the TreadScan system.Uridine 5'-triphosphate promotes in vitro Schwannoma cell migration through matrix metalloproteinase-2 activationAssessment of Nogo-66 receptor 1 function in vivo after spinal cord injury.Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve.Matrix metalloproteinase inhibition enhances the rate of nerve regeneration in vivo by promoting dedifferentiation and mitosis of supporting schwann cellsMultifaceted Roles of Metzincins in CNS Physiology and Pathology: From Synaptic Plasticity and Cognition to Neurodegenerative DisordersImmature astrocytes promote CNS axonal regeneration when combined with chondroitinase ABCMatrix metalloproteinase-9 and -2 expression in the olfactory bulb following methyl bromide gas exposure.Agrin expression during synaptogenesis induced by traumatic brain injuryIndependent evaluation of the anatomical and behavioral effects of Taxol in rat models of spinal cord injury.Antiinflammatory activity of melatonin in central nervous systemStem cells for spinal cord regeneration: Current statusMatrix metalloproteinases, synaptic injury, and multiple sclerosisRole of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury.Beneficial effects of gfap/vimentin reactive astrocytes for axonal remodeling and motor behavioral recovery in mice after stroke.Matrix metalloproteinase-9 controls proliferation of NG2+ progenitor cells immediately after spinal cord injury.Fas/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: implications for translational, clinical application.Enzyme-instructed self-assembly: a multistep process for potential cancer therapyActivation of matrix metalloproteinases-9 after photothrombotic spinal cord injury model in rats.Enhanced expression of matrix metalloproteinase-12 contributes to Npc1 deficiency-induced axonal degeneration.Exploratory study to suggest the possibility of MMP-8 and MMP-9 serum levels as early markers for remission after traumatic spinal cord injury.MT5-MMP, ADAM-10, and N-cadherin act in concert to facilitate synapse reorganization after traumatic brain injuryMatrix metalloproteinases in neuropathic pain and migraine: friends, enemies, and therapeutic targets.Protease-Activated Receptor-1 Supports Locomotor Recovery by Biased Agonist Activated Protein C after Contusive Spinal Cord Injury.alpha-Lipoic acid modulates extracellular matrix and angiogenesis gene expression in non-healing wounds treated with hyperbaric oxygen therapyInduction of mmp-9 expression and endothelial injury by oxidative stress after spinal cord injuryLow-Dose and Short-Duration Matrix Metalloproteinase 9 Inhibition Does Not Affect Adhesion Formation during Murine Flexor Tendon Healing.Peak in matrix metaloproteinases-2 levels observed during recovery from olfactory nerve injury.Targeting MMPs in acute and chronic neurological conditions.Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cordNeurovascular matrix metalloproteinases and the blood-brain barrier.Role of extracellular factors in axon regeneration in the CNS: implications for therapy.Griffonia simplicifolia isolectin B4 identifies a specific subpopulation of angiogenic blood vessels following contusive spinal cord injury in the adult mouse.
P2860
Q27000161-1BB2510A-38D0-4A8A-8708-39A1BE9AF764Q27340373-02714C90-6D3A-4E43-9981-51367C4009CBQ28509307-EF4948A3-6902-43CE-B76B-2EBA95EFD469Q28575871-BA5D90B8-23A8-43C7-AE06-C8C28FEEC06FQ28757375-7CB5C5EE-58E7-4E14-9A10-C8DF8F47C3EDQ30491369-30E9BD7A-8F1C-44B4-855A-8F6ADAC0F89AQ33539984-825BB5B3-1274-442D-B7AF-D4F464E9013FQ33618985-FCF26250-1889-48CB-8E8E-C693583AE2C1Q33721426-BF178136-AB58-4424-B271-977AE7F23202Q33774255-871E6340-C59D-484E-9B1B-F926A972BF15Q33834853-42F8C711-400B-485F-A2A3-491B9E002FAFQ33835294-0DA2C3EC-8040-49D3-B6AE-9F260BA70B06Q33854483-E8968FB9-8F25-43A0-843D-4ACF0680496FQ34134519-307152F0-3056-43CD-B99B-7D8434143C67Q34145243-9E79EA17-0793-4075-A0E5-2A86A337A2E0Q34160609-DE3A643C-223F-4984-8B6E-69BD3905EA06Q34325157-9755046F-DA4A-45E1-A056-46CEDB0A8074Q34402174-E7D0DBEA-9CB7-4C72-8E0C-CE3E28F4F4A2Q34482689-0B4E6905-5789-44D0-AF66-E813311D1628Q34689554-64C6B945-757F-4B99-A934-C1C2FE7A32B3Q34801330-4955538E-3838-4CE7-B033-56F4AAF85748Q35018701-64301158-1CC0-4740-B97E-6A4E4F6942ACQ35209547-5B44D48A-97D5-4FB3-9CB3-68580267B0B6Q35574725-1FD49249-A4B5-458B-AE09-7E4B120B83FFQ35620158-C1E69C87-7A8C-4AFA-89BA-A88EFE266E97Q35627073-B0EABFA5-402A-4BBF-9992-A4993DC37A9FQ35655858-969FAA93-EAA3-4FBF-884A-CD4C2223E9FEQ36067668-EA3F33EE-37FF-43D9-9750-42222CC26FA7Q36079895-5B43E181-44A0-4104-93C8-1C39EB6E4EC4Q36210614-EB9D4F1C-4B6D-4885-8178-9499BD868B26Q36259819-77D491C3-4F6D-4C79-982B-9C93CD249EC2Q36262572-EF901CCA-8F61-4542-B5FF-64662A76341FQ36627288-A6E182DE-2CA5-43E2-89BB-933EBF7E1BEDQ36629809-37C42855-20DD-488A-82B4-EE131DCF94C1Q36720987-B1455551-F982-48D9-9D8B-3B3656A4D9DEQ36963155-80022057-A782-4C17-9D7C-CF7DCBE2AAB3Q37265996-F96D0028-9C07-47E4-B798-59EA59D49681Q37270697-7F8FCF05-E550-41A1-8A51-DC202FECB829Q37306814-042F62F6-86B1-4206-A0A8-8149D9D2B241Q37326075-5BB5EAE2-5909-443F-BA81-798C4B91F671
P2860
Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Matrix metalloproteinase-2 fac ...... very after spinal cord injury.
@en
Matrix metalloproteinase-2 fac ...... very after spinal cord injury.
@nl
type
label
Matrix metalloproteinase-2 fac ...... very after spinal cord injury.
@en
Matrix metalloproteinase-2 fac ...... very after spinal cord injury.
@nl
prefLabel
Matrix metalloproteinase-2 fac ...... very after spinal cord injury.
@en
Matrix metalloproteinase-2 fac ...... very after spinal cord injury.
@nl
P2093
P2860
P1476
Matrix metalloproteinase-2 fac ...... very after spinal cord injury.
@en
P2093
Alpa Trivedi
Jung-Uek Lee
Jung-Yu C Hsu
Linda J Noble-Haeusslein
Robert McKeon
Staci Goussev
P2860
P304
P356
10.1523/JNEUROSCI.1993-06.2006
P407
P50
P577
2006-09-01T00:00:00Z